Midazolam Suppliers & Bulk Manufacturers
Available Forms: Injectable solution (IV/IM)
Available Strengths: 1 mg/mL, 5 mg/mL
Reference Brands: Versed(US); Epistatus(EU)
Category:
Antipsychotropic Drugs
Midazolam is a benzodiazepine used for sedation, anesthesia, and seizure management. Available in injectable, nasal, and oral forms, it's marketed as Versed in the US and Buccolam in the EU. A critical ICU and emergency drug, Midazolam is a key product for pharma B2B distributors and hospital suppliers.
Midazolam is available in Injectable solution (IV/IM)
and strengths such as 1 mg/mL, 5 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Midazolam is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Midazolam can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Midazolam is a fast-acting benzodiazepine used for sedation, anesthesia induction, and seizure control. Available in various forms like injections (1 mg/mL, 5 mg/mL), oral syrup, nasal spray, and buccal solutions, it is widely used in ICU and emergency settings. In the US, it is marketed under brands like Versed and Nayzilam, while in the EU, Buccolam and Epistatus are common. Midazolam is a high-demand product in hospital and ambulatory care, making it a vital listing for pharmaceutical B2B platforms dealing in anesthesia, emergency care, and neurology segments.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing